ENDRA Life Sciences Inc (NDRA)vsWaters Corporation (WAT)
NDRA
ENDRA Life Sciences Inc
$4.33
-2.70%
HEALTHCARE · Cap: $6.07M
WAT
Waters Corporation
$380.30
+0.22%
HEALTHCARE · Cap: $35.11B
Smart Verdict
WallStSmart Research — data-driven comparison
WAT leads profitability with a 11.9% profit margin vs 0.0%. WAT earns a higher WallStSmart Score of 50/100 (C-).
NDRA
Avoid18
out of 100
Grade: F
WAT
Buy50
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for NDRA.
Margin of Safety
-81.9%
Fair Value
$180.97
Current Price
$380.30
$199.33 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Revenue surging 91.4% year-over-year
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Expensive relative to growth rate
ROE of 2.9% — below average capital efficiency
Operating margin of 2.8%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : NDRA
The strongest argument for NDRA centers on Debt/Equity.
Bull Case : WAT
The strongest argument for WAT centers on Revenue Growth, Altman Z-Score, Price/Book. Revenue growth of 91.4% demonstrates continued momentum.
Bear Case : NDRA
The primary concerns for NDRA are Revenue Growth, EPS Growth, Market Cap.
Bear Case : WAT
The primary concerns for WAT are PEG Ratio, Return on Equity, Operating Margin. A P/E of 46.9x leaves little room for execution misses.
Key Dynamics to Monitor
NDRA profiles as a value stock while WAT is a growth play — different risk/reward profiles.
WAT carries more volatility with a beta of 1.20 — expect wider price swings.
WAT is growing revenue faster at 91.4% — sustainability is the question.
NDRA generates stronger free cash flow (-1M), providing more financial flexibility.
Bottom Line
WAT scores higher overall (50/100 vs 18/100) and 91.4% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
ENDRA Life Sciences Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
ENDRA Life Sciences Inc. develops technology for clinical diagnostic ultrasound. The company is headquartered in Ann Arbor, Michigan.
Visit Website →Waters Corporation
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Waters Corporation is a publicly traded Analytical Laboratory instrument and software company headquartered in Milford, Massachusetts.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?